Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Nemaura Med Inc
(NQ:
NMRD
)
0.3150
-0.0310 (-8.96%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Sep 29, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Nemaura Med Inc
< Previous
1
2
3
4
5
Next >
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Appointment of Strategic AI Advisor
September 26, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Present at Emerging Growth in A.I. Conference
September 18, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Issues Update on Nasdaq Compliance Status
September 14, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Issues Update on Nasdaq Compliance Status
September 14, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Interim Results from Its Miboko Program
September 13, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Participate at HLTH 2023
September 12, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Reports Interim Results for 100-Patient Study for sugarBEAT(R)
September 11, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Secures SFDA Approval for sugarBEAT(R)
August 17, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Releases Q1 2023 Financial, Business Report
August 15, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Reports on $6.5M Non-Dilutive Funding
August 14, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Releases Fiscal Year Financial Report, Corporate Update
July 14, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Supply Chain
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Takes Another Step in Commercialization of proBEAT(TM) Platform
June 27, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Participate at Upcoming Collision Conference
June 22, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Showcase Technology at World’s Premier Diabetes Education Event
June 15, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Participating in EF Hutton Fireside Chat
March 21, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Expands EU DuoPack Agreement by Including Insulin as Eligible Drug
March 15, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Intellectual Property
Exposures
Artificial Intelligence
Intellectual Property
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Q3 2023 Results, Provides Business Update
February 24, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Participation at MicroCap Rodeo Winter Wonderland Best Ideas 2023 Conference
February 16, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Nemaura Medical, Inc. (NASDAQ: NMRD) Featured in Coverage of The MicroCap Rodeo’s 3rd Annual Winter Wonderful and Best Ideas Investor Conference
February 09, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Secures ~$8.4M in Registered Direct Offering and Concurrent Private Placement
January 31, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Pricing of ~$8.4M Registered Direct Offering and Concurrent Private Placement
January 27, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces $500K PO from U.S. Health Provider HealthFleet
January 26, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Nemaura Medical Receives First Purchase Order from U.S. Health Provider HealthFleet
January 26, 2023
From
Nemaura Medical, Inc.
Via
Business Wire
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Reports Promising Initial Results from UK NHS Miboko Study
January 24, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Nemaura Medical Reports Initial Patient Data from UK NHS Miboko Study that Demonstrates Weight Loss in 100% of Participants
January 24, 2023
From
Nemaura Medical, Inc.
Via
Business Wire
Sidoti's January Micro-Cap Conference
January 17, 2023
Via
ACCESSWIRE
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Present at Sidoti & Co. Micro Cap Conference
January 11, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) CEO to Present at Planet MicroCap Showcase: Virtual 2022
December 01, 2022
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Nemaura Medical to Present at the Planet MIcroCap Showcase: Virtual 2022
December 01, 2022
From
Nemaura Medical, Inc
Via
GlobeNewswire
InvestorNewsBreaks – Nemaura Medical Inc.’s (NASDAQ: NMRD) Miboko Pilot Program Kicks Off in UK
November 29, 2022
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.